Mankind Pharma announced its acquisition of Bharat Serums and Vaccines Limited (BSV) from Advent International for approximately Rs 13,630 crore. This deal positions Mankind Pharma as a leader in the Indian women's health and fertility drug market, expanding its portfolio to include high-entry barrier products in critical care with established R&D technology platforms.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ac7FyeD
via IFTTT
No comments:
Post a Comment